Over the last 15 years, the monogenic diabetes registry now has over 4,000 patients involved, and from that, the RADIANT study was started to identify new kinds of rare and atypical diabetes. So how can genetics testing and the RADIANT study provide atypical diabetes patients with better diagnoses and treatment? Learn more with Dr. John Buse and Dr. Louis Philipson, Professor in the Department of Medicine and Pediatrics at the University of Chicago.
Diabetes and CKD: Strategies for Diagnosis and Treatment
Uncovering the Prevalence of Type 1 Diabetes in Older Adults
Concentrating on the MOMPOD Trial for Metformin Plus Insulin
Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Overcoming Obesity: Insights from the SURMOUNT-4 Trial
Strategies for Addressing Diabetes Stigma and Discrimination
How the Artificial Pancreas Can Help Diabetic Patients
Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1D
Challenging the Misconception That T1D Is a Childhood-Onset Disease
Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D
Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
How Overnight Glucose Levels Impact Daily Activities in T1D Patients
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
Educating Providers and Patients About Insulin Biosimilars
How Ultra-Processed Foods Increase the Risk of Type 2 Diabetes
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
Guiding Principles of Treating Gestational Diabetes
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video